GET DAILY SIGNALSLegence Corp. (LGN): Assessing the Path to +160% Upside Toward $94
Key Takeaways
- The central price target used here is $94, the rounded arithmetic mean of 17 current analyst price targets for LGN, which average roughly $94.35.
- Individual analyst targets span a wide range from $60 (Barclays) to $130 (Tigress Financial), reflecting sharply different views on data-center demand and profitability.
- At a recent price near $36, reaching $94 would require upside of roughly 160%—a very large move relative to the stock's current level.
- The strongest support comes from record revenue growth, a raised 2026 outlook, and a newly authorized $150 million buyback.
- The biggest risks are margin pressure, analyst target cuts, and regulatory uncertainty over data-center construction permits.
- For more on this ticker's Major News, Today's Price Move, Forecast, and Earnings, explore these dedicated pages for additional context.
- Readers can also explore Trending AI Robots to see how automated strategies are monitoring shifting market conditions.
Analyst Price Targets and Consensus View
Coverage of Legence remains predominantly bullish, though the dispersion is unusually wide. Across 17 verified targets reviewed, the low-to-high range runs from $60 to $130, producing an arithmetic mean of about $94.35, which rounds to the $94 central target used throughout this article. Recent revisions underscore how quickly sentiment has cooled: Barclays (Equal Weight) cut its target from $80 to $60, Stifel (Buy) lowered from $101 to $82, RBC Capital (Outperform) reduced from $101 to $90, and Goldman Sachs moved from $95 to $83. At the other end, Tigress Financial's Ivan Feinseth reiterated a $130 target, while Guggenheim ($115), BofA ($116), BTIG ($100), BMO Capital ($105), and Roth Capital ($120) held above-average objectives. The divergence reflects genuine disagreement over whether Legence's revenue growth can translate into consistent earnings and over the durability of data-center construction demand. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Current Market Position and Path Toward the Target
Legence shares have traded near $36 in recent sessions, well below the 52-week high of $107.24 but above the all-time low of $23.90 reached on Nov. 5, 2026. Reaching the $94 central target would require a gain of roughly 160%, a very large move. The stock's third-quarter report, released Nov. 12, beat expectations: EPS of $1.15 versus a consensus near $0.54, revenue up about 85% year over year to $1.31 billion, and adjusted EBITDA roughly doubling to about $177 million. Management also raised full-year 2026 revenue guidance to $4.87–$4.91 billion and initiated a 2027 outlook of $5.3–$5.6 billion. Yet the shares still traded lower, illustrating how the market is pricing in sector-wide risks rather than rewarding operating results alone.
What Could Support a Move Toward the Target
Legence's growth is real and substantial. The company serves more than 60% of Nasdaq-100 constituents and reported record revenue, backlog, and awarded contracts in its latest quarter, with particular strength in data-center and technology projects. Rising fabrication work has improved margins, and the board's $150 million share-repurchase authorization signals management confidence. If AI capital expenditure stays robust and permitting concerns ease, the combination of accelerating revenue, improving profitability, and a recovering multiple could narrow the enormous gap between the share price and the average analyst price target.
What Could Prevent the Target From Being Reached
The obstacles are equally serious. Legence's post-IPO thesis rests on relentless data-center buildout, and November 2026 midterm results—which empowered candidates favoring data-center moratoriums in states such as Texas—triggered a sharp selloff. A second-quarter adjusted loss of $0.37 per share versus an expected profit exposed margin fragility as revenue mix tilted toward lower-margin installation work. Multiple analysts cut targets through October and November as valuation multiples compressed, and any further regulatory restrictions, project delays, or margin disappointment could keep the stock far from $94. From what I see, this remains a key area to monitor closely.
Technical Levels and Market Structure
Technically, the stock remains in a downtrend. Legence trades well below its 50-day moving average near $48 and its 200-day average near $63, with the 14-day RSI having dipped toward oversold levels near 30. The all-time low of $23.90 represents the primary support zone, while roughly $33 to $36—the breakdown area from early November—now acts as resistance. A durable recovery would likely require reclaiming the low-to-mid $30s before any meaningful move toward higher levels becomes credible.
Time Horizon and What Investors Should Monitor
Most analyst price targets reflect a research horizon of roughly 12 months, though methodologies vary by firm. Investors should watch quarterly margin trends, backlog and book-to-bill metrics, the integration of the Bowers Group acquisition, and whether management defends its raised guidance. Policy developments around data-center permitting, federal depreciation incentives, and hyperscaler capital-spending plans will be decisive, as will any further analyst target revisions. I’m watching this closely as the data-center environment evolves.
Using Tickeron AI Daily Buy/Sell Signals for Market Insights
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a volatile, news-sensitive name like Legence, such tools can help traders discover opportunities, monitor existing positions, and spot shifting trends more efficiently than manual screening. In my view, these signals provide a useful complement when evaluating setups like this one amid shifting sentiment.
Final Assessment
The $94 central target—the average of 17 analyst targets ranging from $60 to $130—sits roughly 160% above the current price, a very large gap that reflects both the severity of the recent selloff and the breadth of opinion about Legence's future. Record revenue, a raised outlook, and a buyback support the bullish case, while margin pressure, analyst downgrades, and regulatory risk to data-center construction weigh against it. The wide target range signals that analysts themselves remain divided on how quickly, if at all, Legence can reclaim lost ground. The path toward $94 depends less on the company's near-term numbers and more on whether the data-center construction environment regains its earlier momentum.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
LGN's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for LGN turned positive on November 11, 2026. Looking at past instances where LGN's MACD turned positive, the stock continued to rise in 8 of 9 cases over the following month. The odds of a continued upward trend are 89%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where LGN's RSI Indicator exited the oversold zone, 1 of 2 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 50%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 9 of 11 cases where LGN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
Following a +26.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where LGN advanced for three days, in 67 of 81 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
LGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LGN as a result. In 14 of 17 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
The Aroon Indicator for LGN entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.575) is normal, around the industry mean (15.143). P/E Ratio (-112.227) is within average values for comparable stocks, (167.534). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.522). Dividend Yield (0.000) settles around the average of (0.215) among similar stocks. P/S Ratio (1.104) is also within normal values, averaging (2.886).
The Tickeron Price Growth Rating for this company is 88 (best 1 - 100 worst), indicating slightly worse than average price growth. LGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry EngineeringConstruction
Advertisement